Component 1

Download Presentation

Layer 1

Watch Video

Thursday, July 20
Moderator: Josh Simmons, MD, FACP

7:30 AM

Genitourinary Cancers

7:40 AM

DEBATE
Adjuvant IO in RCC – Yes vs No
vs

8:05 AM

Biomarker-Based Treatment in Prostate Cancer

8:25 AM

Treatment Updates in Metastatic RCC

8:45 AM

Novel Treatment Options in NMIBC

9:05 AM

Treatment Updates in Metastatic Urothelial Cancer

9:25 AM

Patient-Based Panel Discussion with ASCO Highlights and Q&A
All speakers
Pt case presented by Winship fellow

9:45 AM

Break

Head and Neck

10:15 AM

Novel Systemic Therapy for Head and Neck Cancers

10:30 AM

DEBATE
Surgery Should be Considered the SOC in Low-Risk HPV-Related OPCA – Yes vs No
vs

10:55 AM

Patient-Based Panel Discussion with ASCO Highlights and Q&A
All speakers
Pt case presented by Winship fellow

11:15 AM

Lunch
Moderator: Linda Hendricks, MD
Lymphomas

12:15 PM

How I Evaluate and Treat Patients with Hodgkin Lymphoma

12:35 PM

Updates in CLL Therapy
Susan O’Brien, MD

12:55 PM

DEBATE
Bi-Specifics vs CAR T-cells in NHL
vs

1:15 PM

Novel Therapies for Relapsed T-Cell Lymphoma
Pamela Allen, MD, MSc

1:35 PM

Lessons From Being an Oncologist, Family Caregiver, and Patient

1:55 PM

Patient-Based Panel Discussion with ASH Highlights and Q&A
All speakers
Pt case presented by Winship fellow
2:15 PM
Closing Comments and Adjourn

6:00 PM

Welcome Dinner at Beach Club

Friday, July 21

Moderator: Eric Turner, MD

7:30 AM

Welcome and Day Overview
Suresh Ramalingam, MD, FASCO
Brain Cancers

7:35 AM

Multidisciplinary Management of Brain Tumors

7:50 AM

Management of GBM

8:05 AM

Management of Primary CNS Lymphoma

8:20 AM

Patient-Based Panel Discussion with ASCO Highlights and Q&A
All speakers
Pt case presented by Winship fellow
Melanoma

8:35 AM

Neoadjuvant and Adjuvant Therapy in Melanoma

8:50 AM

Treatment of PD-1-Refractory Melanoma

9:05 AM

DEBATE
Optimal First-Line Therapy for Newly Diagnosed Metastatic Patients – Nivolumab/Relatlimab vs Nivolumab/Ipilimumab
Jacob S. Choi, MD, PhD
vs

9:25 AM

Break
Leukemia

9:50 AM

ALL Research and Therapy in 2023

10:10 AM

DEBATE
Post-transplant Cyclophosphamide Following Allo-HCT is the SOC for Myeloid Neoplasms
vs

10:30 AM

MRD Assessment in Acute Leukemias: How, When, and Really?

10:45 AM

Optimized Use of Targeted Therapeutics in AML

11:00 AM

Treatment Discontinuation in CML

11:15 AM

Patient-Based Panel Discussion with ASH Highlights and Q&A
All speakers
Pt case presented by Winship fellow

11:30 AM

Lunch

Moderator: Frederick Flynt, MD, FACP

Lecture of the Day

12:15 PM

A Global Perspective on Oncology
Gastrointestinal Cancers

12:40 PM

Expanding Treatment Options for Advanced Biliary Tract Cancer

12:55 PM

Current Management of Borderline Resectable/Locally Advanced Pancreatic Cancer
Resectable/Locally Advanced Pancreatic Cancer
Ben George, MD

1:10 PM

DEBATE
Early-Stage MSI-H Rectal Cancer: Surgery First vs IO First
Virginia Shaffer, MD
vs

1:35 PM

Updates in Metastatic Colon Cancer

1:50 PM

Patient-Based Panel Discussion with ASCO Highlights and Q&A
All speakers
Pt case presented by Winship fellow

2:10 PM

Closing Comments and Adjourn

Saturday, July 22

Moderator: Michael Andrews, MD

8:00 AM

Welcome and Day Overview
Thoracic Cancers

8:05 AM

Targeted Therapy in 2023

8:20 AM

DEBATE
Neoadjuvant vs Adjuvant Therapy in Resectable NSCLC
vs

8:40 AM

Advances in Small Cell Lung Cancer Therapy

8:55 AM

New Era of Perioperative Therapy in NSCLC

9:10 AM

What is New in IO Therapy in Advanced NSCLC

9:25 AM

Evolving Landscape of Stage III NSCLC

9:40 AM

Patient-based Panel Discussion with ASCO Highlights and Q&A
All speakers
Pt case presented by Winship fellow

10:00 AM

Break
Gynecologic Cancers

10:20 AM

The ABCs of ADCs in Ovarian Cancer

10:30 AM

Updates on Targeted Therapies, ADCs, and Immunotherapy for Advanced or Recurrent Cervical Cancer

10:45 AM

DEBATE
The Age of Radiation is OVER in Advanced Endometrial Cancer with the Advent of Combined Chemotherapy and Immunotherapy: Yes vs No
vs
Lecture of the Day

11:05 AM

Myeloma as a Paradigm for Targeting the Tumor in its Microenvironment

Q&A moderated by Medical Oncology fellow

11:30 AM

Lunch

Moderator: Sarah Friend, MD

Myeloma

12:15 PM

Smoldering Myeloma – Who Will Need Early Treatment vs Watchful Waiting?

12:35 PM

DEBATE
Early vs Deferred Transplant in MM
vs

12:55 PM

Novel Combination Therapies in Upfront Treatments – Evidence for Quadruplets

1:15 PM

DEBATE
Who is the Right Patient for CART vs Bispecific Antibodies?
vs

1:35 PM

Waldenstrom’s Macroglobulinemia – Approach to Diagnosis and Treatment

1:55 PM

Patient-based Panel Discussion with ASH Highlights and Q&A
All speakers
Pt case presented by Winship fellow

2:10 PM

Closing Comments and Adjourn

5:00 PM

Closing Reception at Beach Club

Sunday, July 23

Moderator: Melissa Dillmon, MD

8:00 AM

Welcome and Day Overview
Breast Cancer

8:05 AM

Surgical Therapy in the Setting of Metastatic Breast Cancer

8:25 AM

DEBATE
Stereotactic Body Radiation Therapy for Oligometastatic Breast Cancer
vs

8:45 AM

Evolving Landscape in HR+/HER2- Metastatic Breast Cancer

9:05 AM

Updates in HER2+ Breast Cancer

9:25 AM

DEBATE
Are all CDK4/6 Inhibitors the Same? Yes vs No
vs

9:45 AM

Metastatic Triple Negative Breast Cancer: Sequencing Immunotherapy, PARP Inhibitors, and Antibody-Drug Conjugates

10:05 AM

Patient-based Panel Discussion with ASCO Highlights and Q&A
All speakers
Pt case presented by Winship fellow

10:25 AM